APA (7th ed.) Citation

W, Z., J, L., X, G., L, L., H, L., & L, Y. (2025). Engineered celastrol liposomes with glycyrrhizic acid augment synergistic antitumor efficacy in breast cancer. Frontiers in oncology, 15, 1602585. https://doi.org/10.3389/fonc.2025.1602585

Chicago Style (17th ed.) Citation

W, Zhang, Li J, Gao X, Liu L, Liang H, and Yue L. "Engineered Celastrol Liposomes with Glycyrrhizic Acid Augment Synergistic Antitumor Efficacy in Breast Cancer." Frontiers in Oncology 15 (2025): 1602585. https://doi.org/10.3389/fonc.2025.1602585.

MLA (9th ed.) Citation

W, Zhang, et al. "Engineered Celastrol Liposomes with Glycyrrhizic Acid Augment Synergistic Antitumor Efficacy in Breast Cancer." Frontiers in Oncology, vol. 15, 2025, p. 1602585, https://doi.org/10.3389/fonc.2025.1602585.